 | |
| Clinical data | |
|---|---|
| Trade names | Endobil |
| Other names | 3-[3-[2-[2-[2-[3-[(3-Carboxy-2,4,6-triiodophenyl)amino]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]propanoylamino]-2,4,6-triiodobenzoic acid |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.045.875 |
| Chemical and physical data | |
| Formula | C26H26I6N2O10 |
| Molar mass | 1287.925 g·mol−1 |
| 3D model (JSmol) | |
| |
Iodoxamic acid (trade name Endobil) is an organoiodine compound used as a radiocontrast agent. It features both a high iodine content as well as several hydrophilic groups.